Sinocare Inc.

Shenzhen Stock Exchange:300298.SZ

Sector

🏥 Health Care

Industries

💻 Telehealth

🔬 Clinical Trials

🏬 Consumer Packaged Goods

🏥 Hospitals & Clinics

🩺 Medical Instruments

Location

China

Market Cap

USD 1.76 B

Share Price

USD 3.12

Avg Daily Volume

5,582,916

Change (1 day)

-1.04%

Change (1 year)

-15.72%

Change (YTD)

-11.82%

Sinocare Inc. Gross Profit Margin for the year ending December 31, 2024: 54.88%

Sinocare Inc. Gross Profit Margin is 54.88% for the year ending December 31, 2024, a 2.63% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Sinocare Inc. Gross Profit Margin for the year ending December 31, 2023 was 53.48%, a -8.91% change year over year.
Sinocare Inc. Gross Profit Margin for the year ending December 31, 2022 was 58.71%, a -2.10% change year over year.
Sinocare Inc. Gross Profit Margin for the year ending December 31, 2021 was 59.97%, a -8.10% change year over year.
Sinocare Inc. Gross Profit Margin for the year ending December 31, 2020 was 65.25%, a 0.18% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Gross Profit Margin	EBIT Margin	EBITDA Margin	Net Income Margin

Shenzhen Stock Exchange: 300298.SZ

Sinocare Inc.

CEO	Mr. Shao Bo Li
IPO Date	March 19, 2012
Location	China
Headquarters	No. 265 Guyuan Road
Employees	4,809
Sector	🏥 Health Care
Industries Telehealth 🔬 Clinical Trials 🏬 Consumer Packaged Goods 🏥 Hospitals & Clinics 🩺 Medical Instruments

Description

Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strip; Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.